ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Holland Recovering From Coronary Bypass; Henry Kaplan Receives Annual Prentis Award

July 25, 1980

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

ONS elects Officers, Presents Awards

June 4, 1993

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

Utah, Hopkins Get Large Donations To Support Research

October 6, 1995

Young Scientists Get Their Share Of NCI Grants

March 29, 1974